e-learning
resources
Milan 2017
Sunday, 10.09.2017
Lung function, respiratory symptoms and obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and characteristics of Sleep Disordered Breathing in a group of 483 patients with type 2 diabetes
M. Lescouzeres (Toulouse, France)
Source:
International Congress 2017 – Lung function, respiratory symptoms and obstructive sleep apnoea
Session:
Lung function, respiratory symptoms and obstructive sleep apnoea
Session type:
Thematic Poster
Number:
1186
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lescouzeres (Toulouse, France). Prevalence and characteristics of Sleep Disordered Breathing in a group of 483 patients with type 2 diabetes. 1186
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Sleep apnea screening questionnaires in patients with type 2 diabetes.
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018
Prevalence of metabolic syndrome (MS) in a population of apneic patients:
A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012
Sleep-disordered breathing is correlated to renal impairment in patients with diabetes mellitus type 2
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Sleep architecture and type 2 diabetes mellitus: Where’s the link?
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015
Sleep in type II diabetes
Source: Annual Congress 2003 - Cough and sleep disorders
Year: 2003
Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Prevalence of OSAS in a cohort of 1112 patients hospitalized for hypertension exploration
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Prevalence of sleep disordered breathing in coeliac children
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013
Prevalence and diagnosis of obesity hypoventilation syndrome (OHS) in ambulatory obese patients
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016
Prevalence of obstructive sleep apnoea in men with type 2 diabetes
Source: Eur Respir J 2005; 26: Suppl. 49, 567s
Year: 2005
Liver enzymes in OSA patients at diagnosis: The Mallorca cohort
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Sleep Disordered Breathing association with cardiovascular disease in the French general population
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Prevalence and predictive factors of sleep breathing disorders (SBD) in severe COPD patients
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Type 2 diabetes and the risk for obstructive sleep apnoea in Nigeria
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Prevalence of hyperuricemia in patients with obstructive sleep apnea from the Mallorca cohort
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
Gender differences in comorbidity burden in recently diagnosed obstructive sleep apnea patients
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014
Late Breaking Abstract - An assessment of medical utilization across procedure codes in patients with sleep apnea and type 2 diabetes
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Sleep-disordered breathing is related to Metabolic Syndrome in Outpatients with Diabetes Mellitus Type 2
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept